Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon L Goodman

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|July 22, 2010
Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo studyTobias Bäuerle, Dorde Komljenovic, Maximilian Merz, et al.
Angiogenesis|January 24, 2004
alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitroRiccardo E Nisato, Jean-Christophe Tille, Alfred Jonczyk, et al.
Chembiochem : a European Journal of Chemical Biology|October 6, 2005
Titanium implant materials with improved biocompatibility through coating with phosphonate-anchored cyclic RGD peptidesJörg Auernheimer, Daniel Zukowski, Claudia Dahmen, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
Nonpeptidic α<sub>v</sub> β<sub>3</sub> Integrin Antagonist Libraries: On-Bead Screening and Mass Spectrometric Identification without TaggingChristoph Gibson, Gábor A G Sulyok, Diane Hahn, et al.
Angewandte Chemie (International Ed. in English)|February 13, 2001
Nonpeptidic alpha(v)beta(3) Integrin Antagonist Libraries: On-Bead Screening and Mass Spectrometric Identification without Tagging The authors acknowledge technical assistance from M. Urzinger, B. Cordes, M. Kranawetter, and A. Schröder. Financial support of the Fonds der Chemischen Industrie and the Deutsche Forschungsgemeinschaft is gratefully acknowledgedChristoph Gibson, Gábor A. G. Sulyok, Diane Hahn, et al.
The Journal of Cell Biology|March 30, 2005
Three-dimensional EM structure of the ectodomain of integrin {alpha}V{beta}3 in a complex with fibronectinBrian D Adair, Jian-Ping Xiong, Catherine Maddock, et al.
Biochemical Pharmacology|September 6, 2002
Divalent cations and the relationship between alphaA and betaA domains in integrinsKah-Tong Seow, Jian-Ping Xiong, M Amin Arnaout, et al.
International Journal of Clinical and Experimental Pathology|December 3, 2013
Comparing the expression of integrins αvβ3, αvβ5, αvβ6, αvβ8, fibronectin and fibrinogen in human brain metastases and their corresponding primary tumorsJens Schittenhelm, Annemarie Klein, Marcos S Tatagiba, et al.
Science (New York, N.Y.)|March 9, 2002
Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligandJian-Ping Xiong, Thilo Stehle, Rongguang Zhang, et al.
International Journal of Cancer|May 11, 2013
αv-Integrin isoform expression in primary human tumors and brain metastasesAlexander Vogetseder, Svenja Thies, Barbara Ingold, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|July 22, 2010
Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo studyTobias Bäuerle, Dorde Komljenovic, Maximilian Merz, et al.
Angiogenesis|January 24, 2004
alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitroRiccardo E Nisato, Jean-Christophe Tille, Alfred Jonczyk, et al.
Chembiochem : a European Journal of Chemical Biology|October 6, 2005
Titanium implant materials with improved biocompatibility through coating with phosphonate-anchored cyclic RGD peptidesJörg Auernheimer, Daniel Zukowski, Claudia Dahmen, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
Nonpeptidic α<sub>v</sub> β<sub>3</sub> Integrin Antagonist Libraries: On-Bead Screening and Mass Spectrometric Identification without TaggingChristoph Gibson, Gábor A G Sulyok, Diane Hahn, et al.
Angewandte Chemie (International Ed. in English)|February 13, 2001
Nonpeptidic alpha(v)beta(3) Integrin Antagonist Libraries: On-Bead Screening and Mass Spectrometric Identification without Tagging The authors acknowledge technical assistance from M. Urzinger, B. Cordes, M. Kranawetter, and A. Schröder. Financial support of the Fonds der Chemischen Industrie and the Deutsche Forschungsgemeinschaft is gratefully acknowledgedChristoph Gibson, Gábor A. G. Sulyok, Diane Hahn, et al.
The Journal of Cell Biology|March 30, 2005
Three-dimensional EM structure of the ectodomain of integrin {alpha}V{beta}3 in a complex with fibronectinBrian D Adair, Jian-Ping Xiong, Catherine Maddock, et al.
Biochemical Pharmacology|September 6, 2002
Divalent cations and the relationship between alphaA and betaA domains in integrinsKah-Tong Seow, Jian-Ping Xiong, M Amin Arnaout, et al.
International Journal of Clinical and Experimental Pathology|December 3, 2013
Comparing the expression of integrins αvβ3, αvβ5, αvβ6, αvβ8, fibronectin and fibrinogen in human brain metastases and their corresponding primary tumorsJens Schittenhelm, Annemarie Klein, Marcos S Tatagiba, et al.
Science (New York, N.Y.)|March 9, 2002
Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligandJian-Ping Xiong, Thilo Stehle, Rongguang Zhang, et al.
International Journal of Cancer|May 11, 2013
αv-Integrin isoform expression in primary human tumors and brain metastasesAlexander Vogetseder, Svenja Thies, Barbara Ingold, et al.
Pageof 5